Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
60.39B | 57.74B | 61.81B | 56.58B | 50.05B | 60.27B | Gross Profit |
12.76B | 12.22B | 11.79B | 9.78B | 10.06B | 11.86B | EBIT |
1.35B | 708.00M | 94.00M | -2.23B | -1.02B | -103.00M | EBITDA |
1.56B | 1.25B | 227.00M | -1.59B | -671.00M | 437.00M | Net Income Common Stockholders |
1.04B | 769.00M | -282.00M | -2.02B | -1.12B | 45.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
4.47B | 3.44B | 3.33B | 4.53B | 3.88B | 3.41B | Total Assets |
50.17B | 48.55B | 47.12B | 47.05B | 44.67B | 44.69B | Total Debt |
8.05B | 6.77B | 9.26B | 10.37B | 4.15B | 2.52B | Net Debt |
3.58B | 3.33B | 5.93B | 5.84B | 273.00M | -886.00M | Total Liabilities |
19.48B | 18.27B | 19.25B | 17.90B | 13.27B | 12.08B | Stockholders Equity |
30.69B | 30.29B | 27.87B | 29.14B | 31.40B | 32.62B |
Cash Flow | Free Cash Flow | ||||
2.84B | 2.60B | -1.70B | -5.49B | -1.05B | 277.00M | Operating Cash Flow |
3.85B | 3.72B | -1.33B | -5.17B | -630.00M | 875.00M | Investing Cash Flow |
-1.18B | -1.16B | 1.57B | -118.00M | -111.00M | 423.00M | Financing Cash Flow |
-2.19B | -2.81B | -1.36B | 5.73B | 1.22B | -1.39B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $2.46T | 28.94 | 11.87% | 1.14% | 2.40% | 2.53% | |
75 Outperform | ¥63.15B | 10.76 | 2.51% | 10.32% | 35.08% | ||
74 Outperform | ¥13.58B | 12.49 | 2.27% | 5.02% | 48.98% | ||
73 Outperform | ¥75.95B | 8.93 | 10.13% | 4.80% | 9.90% | 28.80% | |
65 Neutral | €100.93B | 10.95 | 5.34% | 6.35% | 1.72% | 15.08% | |
61 Neutral | $6.69B | 11.69 | 3.01% | 3.94% | 2.60% | -21.51% | |
34 Underperform | ¥9.46B | ― | ― | 7.83% | -548.99% |